Clinical Trial Update: Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

View source ↗

Summary

Clinical trial update examining molecular features that predict response or resistance to trastuzumab in metastatic breast cancer, highlighting potential biomar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Breast Cancer | Status: COMPLETED